# Sildenafil for DCI

> **NCT03028298** · PHASE1 · UNKNOWN · sponsor: **University of Mississippi Medical Center** · enrollment: 24 (estimated)

## Conditions studied

- Subarachnoid Hemorrhage
- Cerebral Vasospasm

## Interventions

- **DRUG:** Low dose sildenafil citrate
- **DRUG:** High dose sildenafil citrate

## Key facts

- **NCT ID:** NCT03028298
- **Lead sponsor:** University of Mississippi Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2022-12
- **Final completion:** 2023-07
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2021-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03028298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03028298, "Sildenafil for DCI". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03028298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*